Top Taiwan Venture Capital Group independently manages funds exceeding NT$12 billion and assists the National Development Fund, the Industrial Development Bureau, and the Small and Medium Enterprise Administration in investing and supporting domestic companies. CID focuses on globally competitive businesses, internationally scalable services, China’s domestic-demand-driven sectors, as well as biopharma, new drugs, equipment, and distribution services within the biotech and healthcare industries, along with other innovative growth-oriented businesses.

Founded in 1979, ITIC has invested in countless startups both domestically and internationally, supporting healthy growth for its portfolio companies. It spans multiple stages of startups and enterprises and integrates possibilities across industries, creating unique opportunities in tech venture capital thanks to its decades of technical expertise and global network.

Sinopac Venture Capital adopts an ecosystem strategy to support deal sourcing, promote business collaboration, and establish strategic alliances to enhance the value of portfolio companies. Founded in January 2003, the firm mainly invests in early-stage, growth, and expansion-stage companies in e-commerce, FinTech, Industry 4.0, automation equipment, cultural and creative industries, and biotech/medical devices. With frequent cross-strait exchanges, Sinopac actively seeks partnerships in China to expand its footprint. The firm’s investment strategy allows staged exits to maintain consistent returns. Combining Sinopac Financial Holdings and external partners, the company develops innovative industry investment businesses and provides operational support to portfolio companies. Investments are primarily registered in Taiwan, with some in the Cayman Islands and the U.S.